-
at Houston, Rice University, Baylor College of Medicine, University of Texas MD Anderson Cancer Center, and Methodist Research Institute. What we want The Institute of Biosciences and Technology (IBT) of Texas
-
therapeutic response and resistance to RAS inhibition in non-small cell lung cancer (NSCLC) in the laboratory of Ferdinandos Skoulidis, MD, PhD at the University of Texas MD Anderson Cancer Center in Houston
-
Evolution Laboratory of Peter Van Loo at the University of Texas MD Anderson Cancer Center. The post holders will spearhead projects in large-scale cancer genomics and evolution. The Cancer Genomics and
Searches related to phd
Enter an email to receive alerts for phd "University of Texas MD Anderson Cancer Center" positions in USA